The evidence for in vivo potentiation of sulfonamides and antibiotics by trimethoprim (2,4-diamino-5-[3,4,5-trimethoxybenzyl]pyrimidine) is reviewed. The proportion of one part trimethoprim to five parts sulfamethoxazole provides substantially increased protection over that of either substance alone against a broad spectrum of pathogenic bacteria. The simultaneous administration of folinic acid or thymidine does not interfere with the potentiative properties of trimethoprim. In some instances, trimethoprim potentiates the in vivo antibacterial activity of antibiotics, but this effect is not consistent either for a particular antibiotic or for a specific organism.
No takes yet. Share an insight, caveat, or question.
E. Grunberg (1973) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: